FDA Inspection 1238690 — Bloodworks
The FDA completed an inspection of Bloodworks on May 3, 2024 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 3, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Seattle, WA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1842 | 21 CFR 211.84(d)(1) | Component identity verification |